Rainer Hamacher

1.8k total citations
64 papers, 1.1k citations indexed

About

Rainer Hamacher is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Rainer Hamacher has authored 64 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Oncology, 30 papers in Pulmonary and Respiratory Medicine and 15 papers in Surgery. Recurrent topics in Rainer Hamacher's work include Peptidase Inhibition and Analysis (22 papers), Sarcoma Diagnosis and Treatment (22 papers) and Radiopharmaceutical Chemistry and Applications (10 papers). Rainer Hamacher is often cited by papers focused on Peptidase Inhibition and Analysis (22 papers), Sarcoma Diagnosis and Treatment (22 papers) and Radiopharmaceutical Chemistry and Applications (10 papers). Rainer Hamacher collaborates with scholars based in Germany, United States and Austria. Rainer Hamacher's co-authors include Dieter Saur, Günter Schneider, Roland M. Schmid, Sebastian Bauer, Wolfgang P. Fendler, Lukas Kessler, Justin Ferdinandus, Maximilian Reichert, Nader Hirmas and Lale Umutlu and has published in prestigious journals such as Journal of Clinical Investigation, The Journal of Experimental Medicine and Journal of Clinical Oncology.

In The Last Decade

Rainer Hamacher

54 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Rainer Hamacher Germany	18	720	354	319	290	175	64	1.1k
Chengrong Xie China	20	772 1.1×	655 1.9×	684 2.1×	395 1.4×	179 1.0×	44	1.5k
Mikio Kawamura Japan	21	501 0.7×	400 1.1×	333 1.0×	224 0.8×	138 0.8×	64	1.2k
Martin Werner Germany	12	252 0.3×	319 0.9×	192 0.6×	226 0.8×	179 1.0×	21	837
Zhenhai Lu China	18	554 0.8×	398 1.1×	273 0.9×	237 0.8×	197 1.1×	55	1.1k
Naotake Funamizu Japan	15	516 0.7×	374 1.1×	294 0.9×	255 0.9×	209 1.2×	82	1.1k
Seiichi Shinji Japan	18	698 1.0×	377 1.1×	361 1.1×	308 1.1×	229 1.3×	107	1.2k
Marta Łukaszewicz‐Zając Poland	20	577 0.8×	301 0.9×	357 1.1×	238 0.8×	133 0.8×	62	1.1k
Yiyan Lei China	20	318 0.4×	434 1.2×	244 0.8×	173 0.6×	203 1.2×	70	1.0k
Victoria J. Christiansen United States	16	580 0.8×	247 0.7×	388 1.2×	108 0.4×	184 1.1×	23	937
Susana Constantino Rosa Santos Portugal	17	464 0.6×	664 1.9×	250 0.8×	68 0.2×	105 0.6×	41	1.3k

Countries citing papers authored by Rainer Hamacher

Since Specialization

Citations

This map shows the geographic impact of Rainer Hamacher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rainer Hamacher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rainer Hamacher more than expected).

Fields of papers citing papers by Rainer Hamacher

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rainer Hamacher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rainer Hamacher. The network helps show where Rainer Hamacher may publish in the future.

Co-authorship network of co-authors of Rainer Hamacher

This figure shows the co-authorship network connecting the top 25 collaborators of Rainer Hamacher. A scholar is included among the top collaborators of Rainer Hamacher based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rainer Hamacher. Rainer Hamacher is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Falkenhorst, Johanna, Philipp Ivanyi, Rainer Hamacher, et al.. (2025). Phase II Trial of Ponatinib in Patients with Metastatic Gastrointestinal Stromal Tumor following Failure or Intolerance of Prior Therapy with Imatinib (POETIG Trial). Clinical Cancer Research. 31(19). 4059–4069.

Liffers, Sven‐Thorsten, Johanna Falkenhorst, Wiebke K. Guder, et al.. (2025). Solitary fibrous tumor: a retrospective analysis of clinicopathological characteristics and palliative treatment of 67 cases. 3. 100017–100017.

Watanabe, Masao, Wolfgang P. Fendler, Hong Grafe, et al.. (2024). Prognostic Implications of⁶⁸Ga-FAPI-46 PET/CT–Derived Parameters on Overall Survival in Various Types of Solid Tumors. Journal of Nuclear Medicine. 65(7). 1027–1034. 9 indexed citations

Hardes, Jendrik, Abbas Agaimy, Stéphane Collaud, et al.. (2024). Prognostic factors in clear cell sarcoma: an analysis of soft tissue sarcoma in 43 cases. Journal of Cancer Research and Clinical Oncology. 150(11). 494–494. 1 indexed citations

Pabst, Kim M., Marija Trajkovic‐Arsic, Phyllis F. Cheung, et al.. (2023). Superior Tumor Detection for⁶⁸Ga-FAPI-46 Versus¹⁸F-FDG PET/CT and Conventional CT in Patients with Cholangiocarcinoma. Journal of Nuclear Medicine. 64(7). 1049–1055. 32 indexed citations

Lückerath, Katharina, Jens T. Siveke, Benedikt M. Schaarschmidt, et al.. (2023). Novel Ga-68-FAPI PET/CT offers oncologic staging without COVID-19 vaccine-related pitfalls. Nuklearmedizin - NuclearMedicine. 62(2). 129–129. 2 indexed citations

Fendler, Wolfgang P., Kim M. Pabst, Rainer Hamacher, et al.. (2023). ⁶⁸Ga-FAPI-46 PET for cancer imaging: A prospective single-arm clinical trial.. Journal of Clinical Oncology. 41(16_suppl). 3064–3064. 1 indexed citations

Hamacher, Rainer, et al.. (2023). Diagnostik und Behandlung von Weichgewebesarkomen. 29(11). 1009–1018.

Milošević, Aleksandar, Rainer Hamacher, Johannes Haubold, et al.. (2023). Impact of CT and MRI in the diagnostic workup of malignant triton tumour—a monocentric analysis and review of the literature. British Journal of Radiology. 97(1154). 430–438.

10.

Fendler, Wolfgang P., Kim M. Pabst, Lukas Kessler, et al.. (2022). Safety and Efficacy of 90Y-FAPI-46 Radioligand Therapy in Patients with Advanced Sarcoma and Other Cancer Entities. Clinical Cancer Research. 28(19). 4346–4353. 91 indexed citations

11.

Störk, Theresa, Balázs Hegedűs, Wiebke K. Guder, et al.. (2022). Prognostic Factors for Leiomyosarcoma with Isolated Metastases to the Lungs: Impact of Metastasectomy. Annals of Surgical Oncology. 29(7). 4429–4436. 3 indexed citations

12.

Kowalski, Axel, Benjamin Weismüller, Mitra Tewes, et al.. (2022). Cancer Patients’ Age-Related Benefits from Mobile Neurofeedback-Therapy in Quality of Life and Self-efficacy: A Clinical Waitlist Control Study. Applied Psychophysiology and Biofeedback. 48(2). 217–227. 7 indexed citations

13.

Pabst, Kim M., Ken Herrmann, Christoph Rischpler, et al.. (2022). Thyroiditis: A pitfall in Ga-68-FAPI-PET/CT?. Nuklearmedizin - NuclearMedicine. 61(2). 195–195.

14.

Brodowicz, Thomas, Bernadette Liegl‐Atzwanger, Nicolas Penel, et al.. (2020). Assessing Prognostic and Predictive Biomarkers of Regorafenib Response in Patients with Advanced Soft Tissue Sarcoma: REGOSARC Study. Cancers. 12(12). 3746–3746. 8 indexed citations

15.

Brodowicz, Thomas, et al.. (2017). Pembrolizumab (PEM) in patients with advanced/metastatic bone sarcoma (BS) or soft tissue sarcoma (STS): Named patient use by the Medical University of Vienna. Annals of Oncology. 28. v533–v533.

16.

Hamacher, Rainer, Marit Ahrens, Kirsten Reuter‐Jessen, et al.. (2017). PD-L1 inhibition – a new therapeutic opportunity in cutaneous angiosarcoma?. Annals of Oncology. 28. v532–v533. 3 indexed citations

17.

Schur, Sophie, Rainer Hamacher, & Thomas Brodowicz. (2016). Pazopanib in Primary Cardiac Angiosarcoma of the Right Atrium: A Case Report. Case Reports in Oncology. 9(2). 363–367. 13 indexed citations

18.

Hamacher, Rainer, Roland M. Schmid, Dieter Saur, & Günter Schneider. (2008). Apoptotic pathways in pancreatic ductal adenocarcinoma. Molecular Cancer. 7(1). 64–64. 101 indexed citations

19.

Reichert, Maximilian, Dieter Saur, Rainer Hamacher, Roland M. Schmid, & Günter Schneider. (2007). Phosphoinositide-3-Kinase Signaling Controls S-Phase Kinase–Associated Protein 2 Transcription via E2F1 in Pancreatic Ductal Adenocarcinoma Cells. Cancer Research. 67(9). 4149–4156. 87 indexed citations

20.

Schneider, Günter, Maximilian Reichert, Dieter Saur, et al.. (2007). HDAC3 is linked to cell cycle machinery in MiaPaCa2 cells by regulating transcription of skp2. Cell Proliferation. 40(4). 522–531. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact